Salixpirin
Natural health product licensed in Canada
- Other names
- Dispirin, KONIG Dispirin, KONIG Salixpirin
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80043916
- Status
- Active licence
- Licence date
- 30 July 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salix alba Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2,650 mg Potency : 15 % Salicin | 265 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Gélatine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | 19 years | 1 Capsule | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Used in Herbal Medicine for short-term relief of low back pain. Traditionally used in Herbal Medicine for the relief of minor joint pain (due to osteoarthritis) and/or to relieve fever associated with the common cold and/or to relieve headache pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen, if you have asthma or peptic ulcer disease or if you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates. Discontinue use and consult a health care practitioner if you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhea.
- Contre-indications
Do not take this product if you are allergic to acetylsalicylic acid (ASA) or other salicylates, if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80043916
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.